Female Sex and Increased Immune Marker mRNA Gene Expression are Associated With Decreased Overall Survival in Patients With HPV-Negative Head and Neck Cancer

被引:0
|
作者
Tobillo, R. [1 ]
De Joya, E. [2 ]
Dooley, S. [3 ]
Freedman, L. M. [4 ]
Sargi, Z. [5 ]
Weed, D. [5 ]
Perez, C. [6 ]
Samuels, M. A. [3 ]
Samuels, S. [7 ]
Carmona, R. [3 ]
机构
[1] Univ Miami, Dept Radiat Oncol, Jackson Hlth Syst, Miami, FL USA
[2] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[3] Univ Miami, Dept Radiat Oncol, Sylvester Comprehens Canc Ctr, Miami, FL USA
[4] Sylvester Comprehens Canc Ctr, Dept Radiat Oncol, Miami, FL USA
[5] Univ Miami, Dept Radiat Oncol, Sylvester Comprehens Canc Ctr, Miami, FL USA
[6] Univ Miami, Dept Med Oncol, Sylvester Comprehens Canc Ctr, Miami, FL USA
[7] Univ Miami, Dept Radiat Oncol, Miami, FL USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2475
引用
收藏
页码:E238 / E239
页数:2
相关论文
共 50 条
  • [41] Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients
    Chann Lagadec
    Erina Vlashi
    Sunita Bhuta
    Chi Lai
    Paul Mischel
    Martin Werner
    Michael Henke
    Frank Pajonk
    BMC Cancer, 14
  • [42] Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients
    Lagadec, Chann
    Vlashi, Erina
    Bhuta, Sunita
    Lai, Chi
    Mischel, Paul
    Werner, Martin
    Henke, Michael
    Pajonk, Frank
    BMC CANCER, 2014, 14
  • [43] Human Immunodeficiency Virus (HIV) Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer
    Salahuddin, Syim
    Cohen, Oded
    Wu, Margaret
    Irizarry, Javier Perez
    Vega, Teresita
    Gan, Geliang
    Deng, Yanhong
    Isaeva, Natalia
    Prasad, Manju
    Schalper, Kurt A.
    Mehra, Saral
    Yarbrough, Wendell G.
    Emu, Brinda
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (08) : 1449 - 1458
  • [44] Patients' sex and PD-L1 expression jointly associated with overall survival benefits of immune checkpoint inhibitors in cancer
    Yu, Y.
    Li, A.
    Chen, Y.
    Zhang, W.
    Zhong, H.
    Gu, Y.
    Ou, Q.
    Xia, J.
    Lin, D.
    Fu, T.
    Li, L.
    Liu, R.
    Yao, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S713 - S713
  • [45] Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors
    Foster, Corey C.
    Couey, Marcus A.
    Kochanny, Sara E.
    Khattri, Arun
    Acharya, Rajesh K.
    Tan, Yi-Hung Carol
    Brisson, Ryan J.
    Leidner, Rom S.
    Seiwert, Tanguy Y.
    CANCER, 2021, 127 (24) : 4565 - 4573
  • [46] HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer
    Mehdi, Ahmed M.
    Zhou, Chenhao
    Turrell, Gavin
    Walpole, Euan
    Porceddu, Sandro
    Frazer, Ian H.
    Chandra, Janin
    CANCER GENE THERAPY, 2023, 30 (04) : 629 - 640
  • [47] HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer
    Ahmed M. Mehdi
    Chenhao Zhou
    Gavin Turrell
    Euan Walpole
    Sandro Porceddu
    Ian H. Frazer
    Janin Chandra
    Cancer Gene Therapy, 2023, 30 : 629 - 640
  • [48] Increased Notch1 Expression Is Associated With Poor Overall Survival in Patients With Ovarian Cancer
    Alniaimi, Ahmed Numan
    Demorest-Hayes, Kristin
    Alexander, Vinita M.
    Seo, Songwon
    Yang, David
    Rose, Stephen
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (02) : 208 - 213
  • [49] Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer
    Tao Wu
    Yi Li
    Jianguo Lu
    Qing Qiao
    Guoqiang Bao
    Nan Wang
    Xianli He
    Xilin Du
    Medical Oncology, 2013, 30
  • [50] Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer
    Wu, Tao
    Li, Yi
    Lu, Jianguo
    Qiao, Qing
    Bao, Guoqiang
    Wang, Nan
    He, Xianli
    Du, Xilin
    MEDICAL ONCOLOGY, 2013, 30 (01)